Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Cytotoxic gigantecin analogue presented at ACS meeting

Sep. 3, 1998

WHI reports design, synthesis and pharmacological evaluation of new agent for glioblastoma

Sep. 3, 1998

FDA advisory committee recommends clearance for Valstar

Sep. 3, 1998

Nolvadex recommended for approval in U.S., to be copromoted by Zeneca and Roche

Sep. 3, 1998

Antitumor imidazoacridone available for licensing from BTG

Sep. 3, 1998

Protegrin analogue safe in cancer patients receiving chemotherapy

Sep. 3, 1998

Novartis describes search for potent and selective CDK1/CDK2 inhibitors

Sep. 2, 1998

AEterna isolates molecule exhibiting anti-MMP activity

Sep. 2, 1998

Orphan drug designation granted for thalidomide in KS

Sep. 1, 1998

News from the ACS: Btk inhibitor LFM-A13 promotes apoptosis in leukemia cells

Sep. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
Other news to note for July 20, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Cellution, Dimerix, Elutia, IPG, Jasper, Kira, Lumibird, Medtronic,...